Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: Metabolic index and perfusion index

Dementia and Geriatric Cognitive Disorders

Volumn 20, Issue 2-3, 2005, Pages 63-70

  Döbert, Natascha ^a   Pantel, Johannes ^a   Frölich, Lutz ^b   Hamscho, Nadja ^a   Menzel, Christian ^a   Grünwald, Frank ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Metabolic index; Mild cognitive impairment; Mild dementia; Perfusion index; Positron emission tomography; Regional cerebral blood flow; Single photon emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; HUMAN; LEFT HEMISPHERE; MALE; MIXED ANXIETY AND DEPRESSION; MULTIINFARCT DEMENTIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; RIGHT HEMISPHERE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; BRAIN; BRAIN CHEMISTRY; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; DEMENTIA; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 23944501555     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085857     Document Type: Article

References (35)

1. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM: Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer's disease treatment studies. Am J Psychiatry 2002;159:738-745.
2. Herholz K: FDG PET and Differential Diagnosis of Dementia. Alzheimer Dis Assoc Disord 1995;9;6-16.
3. De Leon MJ, Ferris SH, George AE, et al: Computed tomography and positron emission transaxial evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab 1983;3:391-394.
4. Ibanez V, Pietrini P, Alexander GE, et al: Abnormal metabolic patterns in Alzheimer's disease after correction for partial volume effects. Neurology 1998;50:1585-1593.
5. Duara R, Grady CL, Haxby JV, Sundaram M, et al: Positron emission tomography in Alzheimer's disease. Neurology 1986;36:879-887.
6. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
7. Reiman EM, Caselli RJ, Yun LS, et al: Preclinical evidence of genetic risk factor for Alzheimer's disease in apoprotein E type 4 homozygotes using positron emission tomography. N Engl J Med 1996;334:752-758.
8. Johnson KA, Jones BL, Holman JA, et al: Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-1571.
9. Kogure D, Matsuda H, Ohnishi T, et al: Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000;41:1155-1162.
10. Friedland RP, Budinger TF, Koss B, Ober AB: Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 1985;53:235-240.
11. Silverman DH, Small GW, Chang CY, Lu CS, et al: Positron emission tomography in evaluation of dementia. JAMA 2001;286:2120-2127.
12. Hoffman JM, Welsh-Bohmer KA, Hanson W, et al: FDG-PET imaging in patients with pathologically verified dementia. J Nucl Med 2000;41:1920-1928.
13. Bonte FJ, Tintner R, Weiner MF, Bigio EH, et al: Brain blood flow in the dementias: SPECT with histopathologic correlation. Radiology 1993;186:361-365.
14. Peters JM, Hummel T, Kratzsch T, Lotsch J, Skarke C, Frölich L: Olfactory function in mild cognitive impairment and Alzheimer's disease: An investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 2003;160:1995-2002.
15. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Berejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, De-Carli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmenn A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
16. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
18. Erzigkeit H: The SKT - A short cognitive performance test as an instrument for the assessment of clinical efficacy of cognition enhancers; in Bergener M, Reisberg B (eds): Diagnosis and Treatment of Senile Dementia. New York, Springer, 1989, pp 164-174.
19. Reisberg B, Ferris SH, De Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
21. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Berejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, De-Carli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmenn A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
22. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäkman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, DeLeon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, Van Duijn C, Visser P, Petersen RC: Mild cognitive impairment - beyond controversies, towards a consensus: Report of the International Workshop on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
23. Zaudig M: A new systematic method of measurement and diagnosis of 'mild cognitive impairment' and dementia according to ICD-10 and DSM-III-R criteria. Int Psychogeriatr 1992;4(suppl 2):203-219.
24. Bonte FJ, Weiner MF, Bigio EH, White CI: Brain blood flow in the dementias: SPECT with histopathologic correlations in 54 patients. Radiology 1997;202:793-797.
25. Talbot PR, Snowden JS, Lloyd JJ, Neary D, et al: The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. J Neurol 1995;242:579-586.
26. Kim JM, Stewart R, Shin IS, Choi SK, Yoon JS: Subjective memory impairment, cognitive function and depression - a community study in older Koreans. Dement Geriatr Cogn Disord 2003;15:218-225.
27. Herholz K, Schopphoff H, Schmidt M, et al: Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. J Nucl Med 2002;43:21-26.
28. Herholz K, Salmon E, Perani D, et al: Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002;17:302-316.
29. Jobst KA, Barnetson LP, Shepstone BJ: Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: The use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging. Int Psychogeriatr 1997;9(suppl 1):191-222.
30. Grünwald F, Horn R, Rieker O, et al: HM-PAO-SPECT in Alzheimer-type dementia and major depression with memory disorders. Nuklearmedizin 1993;32:128-133.
31. Messa C, Perani D, Lucignani G, et al: High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: Comparison with fluorine-18-FDG-PET. J Nucl Med 1994;35:210-216.
32. Zubal IG, Avery RA, Stokking R, Studholme C, Corsi M, Dey H, Seibyl JP, Spencer SS: Ratio-images calculated from interictal positron emission tomography and single-photon emission computed tomography for quantification of the uncoupling of brain metabolism and perfusion in epilepsy. Epilepsia 2000;41:1560-1566.
33. Pantel J, Schröder J, Schad LR, Friedlinger M, Knopp MV, Schmitt R, Geissler M, Blüml S, Essig M, Sauer H: Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol Med 1997;27:221-229.35.
34. Pantel J, Kratz B, Essig M, Schröder J: Parahippocampal volume reduction in aging-associated cognitive decline. Am J Psychiatry 2003;160:379-382.
35. Pantel J, Schröder J, Essig M, Minakaran R, Schad LR, Friedlinger M, Jauss M, Knopp MV: Corpus callosum in Alzheimer's disease and vascular dementia - a quantitative magnetic resonance study. J Neural Transm Suppl 1998;54:129-136.